This is the authors' abstract. We don't add key points for this paper.
Nemolizumab has a rapid and robust onset of action in PN with itch reduction and improvement of sleep within 48 h.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ständer et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: